Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Ivor, Caro"'
Autor:
Shahneen Sandhu, Victoria Atkinson, Maria González Cao, Theresa Medina, Ainara Soria Rivas, Alexander M. Menzies, Ivor Caro, Louise Roberts, Yuyao Song, Yibing Yan, Yu Guo, Cloris Xue, Georgina V. Long
Publikováno v:
European Journal of Cancer. 178:180-190
Autor:
Paolo A Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Jacob Schachter, Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Grant A McArthur, Ralf Gutzmer
Publikováno v:
The Lancet Oncology. 24:33-44
Autor:
Giulio, Barteselli, Grant R, Goodman, Yogesh, Patel, Ivor, Caro, Cloris, Xue, Samuel, McCallum
Publikováno v:
Drug Safety. 45:1491-1499
Serous retinopathy can be associated with MEK inhibitors, including cobimetinib. We present results of an integrated safety analysis to further characterize ocular functional and structural changes due to serous retinopathy.Four studies evaluating co
Autor:
Antoni Ribas, Yibing Yan, Lukas Amler, Ilsung Chang, Huibin Yue, Luciana Molinero, Priti S. Hegde, Isabelle Rooney, Ivor Caro, Stephen D. Hurst, Mark Kockx, Luc Andries, Jeffrey Sosman, Paolo A. Ascierto, James Larkin, Brigitte Dréno, Grant A. McArthur, Matthew J. Wongchenko
Supplementary Figure S3. Association of the cell cycle/immune signature with B, lactate dehydrogenase levels.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea914eb36a0663bbdbd8e1f2b2f8083
https://doi.org/10.1158/1078-0432.22466237.v1
https://doi.org/10.1158/1078-0432.22466237.v1
Autor:
Antoni Ribas, Grant A. McArthur, Isabelle Rooney, Ivor Caro, Ilsung Chang, Jessie J. Hsu, Hartmut Koeppen, Zhen Shi, Jeffrey A. Sosman, Paul B. Chapman, Claus Garbe, Michele Maio, Brigitte Dréno, Paolo A. Ascierto, James Larkin, Caroline Robert, Matthew J. Wongchenko, Yibing Yan
Supplementary Table S2 from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAFV600-mutated Metastatic Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106f378d2a08066694f44fd4747cabcb
https://doi.org/10.1158/1078-0432.22469670
https://doi.org/10.1158/1078-0432.22469670
Autor:
Antoni Ribas, Yibing Yan, Lukas Amler, Ilsung Chang, Huibin Yue, Luciana Molinero, Priti S. Hegde, Isabelle Rooney, Ivor Caro, Stephen D. Hurst, Mark Kockx, Luc Andries, Jeffrey Sosman, Paolo A. Ascierto, James Larkin, Brigitte Dréno, Grant A. McArthur, Matthew J. Wongchenko
Purpose: The association of tumor gene expression profiles with progression-free survival (PFS) outcomes in patients with BRAFV600-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib was evaluated.Experimental Design: G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ecddf22667cc71d93b7b2572ce9e18d
https://doi.org/10.1158/1078-0432.c.6526268
https://doi.org/10.1158/1078-0432.c.6526268
Autor:
Antoni Ribas, Grant A. McArthur, Isabelle Rooney, Ivor Caro, Ilsung Chang, Jessie J. Hsu, Hartmut Koeppen, Zhen Shi, Jeffrey A. Sosman, Paul B. Chapman, Claus Garbe, Michele Maio, Brigitte Dréno, Paolo A. Ascierto, James Larkin, Caroline Robert, Matthew J. Wongchenko, Yibing Yan
Purpose: Previous investigations identified transcriptional signatures associated with innate resistance to anti–programmed cell death protein 1 therapy in melanoma. This analysis aimed to increase understanding of the role of baseline genetic feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76f7980bef6bc5020714c3e5ad86bf9
https://doi.org/10.1158/1078-0432.c.6527310.v1
https://doi.org/10.1158/1078-0432.c.6527310.v1
Autor:
Frederic J. de Sauvage, Ivor Caro, Ervin H. Epstein, James C. Marsters, Lee L. Rubin, Angela Wu, Elana Shpall, Kris S. Chang, Karen Kotkow, Frank Wang, Robert L. Yauch, Ling Fu, Christopher A. Callahan, Mike Reich, Dongwei Li, Jean Y. Tang, Tracy Tang
Supplementary Materials and Methods; Supplementary Tables S1-S4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5843873f54a17988876092c3b15e71ba
https://doi.org/10.1158/1078-0432.22440850.v1
https://doi.org/10.1158/1078-0432.22440850.v1
Autor:
Antoni Ribas, Grant A. McArthur, Isabelle Rooney, Ivor Caro, Ilsung Chang, Jessie J. Hsu, Hartmut Koeppen, Zhen Shi, Jeffrey A. Sosman, Paul B. Chapman, Claus Garbe, Michele Maio, Brigitte Dréno, Paolo A. Ascierto, James Larkin, Caroline Robert, Matthew J. Wongchenko, Yibing Yan
Supplementary Data from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAFV600-mutated Metastatic Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30787636d7b7da31aab89ab7e3b8cd8d
https://doi.org/10.1158/1078-0432.22469679.v1
https://doi.org/10.1158/1078-0432.22469679.v1
Autor:
Antoni Ribas, Yibing Yan, Lukas Amler, Ilsung Chang, Huibin Yue, Luciana Molinero, Priti S. Hegde, Isabelle Rooney, Ivor Caro, Stephen D. Hurst, Mark Kockx, Luc Andries, Jeffrey Sosman, Paolo A. Ascierto, James Larkin, Brigitte Dréno, Grant A. McArthur, Matthew J. Wongchenko
Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e6bbb305788c7d2546723e62a30a8d0
https://doi.org/10.1158/1078-0432.22466228
https://doi.org/10.1158/1078-0432.22466228